Certolizumab pegol for the treatment of psoriatic arthritis: 4-year outcomes from the RAPID-PsA trial

P. Goupille, P. J. Mease, R. Fleischmann, J. Wollenhaupt, A. Deodhar, D. Gladman, B. Hœpken, L. Peterson, D. Van Der Heijde

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)A222-A223
JournalRevue du Rhumatisme (Edition Francaise)
StatePublished - Nov 1 2016

ASJC Scopus subject areas

  • Rheumatology

Cite this